Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Nutex Health (NUTX) EPS (Weighted Average and Diluted) (2016 - 2025)

Nutex Health's EPS (Weighted Average and Diluted) history spans 11 years, with the latest figure at $2.17 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 81.23% year-over-year to $2.17; the TTM value through Dec 2025 reached $10.48, up 8.15%, while the annual FY2025 figure was $10.48, 8.15% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $2.17 at Nutex Health, down from $7.76 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $11.56 in Q4 2024 and bottomed at -$99.74 in Q4 2022.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.08 (2024), against an average of -$5.2.
  • The largest annual shift saw EPS (Weighted Average and Diluted) plummeted 6100.0% in 2023 before it skyrocketed 3300.0% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.09 in 2021, then plummeted by 110922.22% to -$99.74 in 2022, then skyrocketed by 89.6% to -$10.37 in 2023, then soared by 211.48% to $11.56 in 2024, then plummeted by 81.23% to $2.17 in 2025.
  • Per Business Quant, the three most recent readings for NUTX's EPS (Weighted Average and Diluted) are $2.17 (Q4 2025), $7.76 (Q3 2025), and -$2.01 (Q2 2025).